doi:10.3969/j.issn.1673-8640.2015.06.012

Abstract

CLC Number:

R446.1

Figures/Tables 1

References 12

[1]	SARKAR PK,LAMBERT LA.Aetiology and treatment of hyperhomocysteinaemia causing ischaemic stroke[J].Int J Clin Pract,2001,55(4):262-268.
[2]	中华医学会内分泌学分会,《中国甲状腺疾病诊治指南》编写组.中国甲状腺疾病诊治指南——甲状腺疾病的实验室及辅助检查[J].中华内科杂志,2007,46(8):697-702.
[3]	李利娟,张翠玲.老年原发性甲状腺功能减退症误诊原因分析[J].中国热带医学,2008,8(6):942-943.
[4]	李京丽,秦丹丹,李昭荚.原发性甲状腺功能减退症与血脂代谢的相关性研究[J].中华临床医师杂志:电子版,2013,7(21):9480-9484.
[5]	郗光霞,雷昆.甲减患者总同型半胱氨酸水平及其相关因素分析[J].中国误诊学杂志,2001,1(9):1296-1298.
[6]	NAESS H,NYLAND H, IDICULA T,et al.C-reactive protein and homocysteine predict long-term mortality in yong ischemic stroke patients[J]. J Stroke Cerebrovasc Dis,2013,22(8):e435-e440.
[7]	ALSULAIMANI S, GARDENER H, ELKIND MS,et al.Elevated homocysteine and carotid plaque area and densitometry in the Northen Manhattan Study[J].Stroke,2013,44(2):457-461.
[8]	彭乃杰,李克诚,夏菲,等. 血清同型半胱氨酸水平与急性脑梗死的相关性研究[J]. 检验医学,2013,28(3): 257-258.
[9]	吴仕君,王胜梅. 冠心病患者血清Hcy和Cys C水平的变化[J]. 检验医学,2014,29(4): 327.
[10]	李媛媛,王琪. 同型半胱氨酸及血管内皮功能检测在脑梗死中的应用[J]. 检验医学,2014,29(10): 1028-1030.
[11]	MORRIS MS,BOSTOM AG,JACQUES PF,et al.Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey[J].Athemselerosis,2001,155(1):195-200.
[12]	刘虹,李勇,李松,等.同型半胱氨酸与心血管疾病研究的进展[J].中华儿科杂志,2000,38(7):460-461.

组别	例数	Hcy(μmol/L)	LDL-C(mmol/L)	FA(nmol/L)	Vit B12(pmol/L)
甲减组	35	19.51±7.59^*	4.45±1.24^*	10.07±1.52^*	367.45±41.14
正常对照组	35	9.14±3.19	2.27±0.81	15.43±1.87	357.67±37.04

组别	例数	Hcy(μmol/L)	LDL-C(mmol/L)	FA(nmol/L)	Vit B12(pmol/L)
甲减组	35	19.51±7.59^*	4.45±1.24^*	10.07±1.52^*	367.45±41.14
正常对照组	35	9.14±3.19	2.27±0.81	15.43±1.87	357.67±37.04

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 1

References 12

Related Articles 15

Recommended Articles

Metrics